Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOMAGE spironolactone biomarker-guided heart failure prevention trial
NL-OMON44913Phase 2Active, not recruiting
- Sponsor
- ACS Biomarker
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of spironolactone in heart failure (HF) (2 arms), sponsored by ACS Biomarker. Started Mar 2016; status: active, not recruiting.
02
Drugs
spironolactone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NL-OMON44913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44913.